Ligand Pharmaceuticals Inc (LGND)

Free Cash Flow Growth

53.96%

Quarterly · Period ending:

LGND logo

LGND Free Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported53.96%
LGND Quarterly Free Cash Flow YoY % (-6.67% → 53.96%)
High-resolution chart · PNG

LGND free cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Free Cash Flow Growth — Quarterly
Period endingFree Cash Flow Growth
53.9627%
288.3521%
65.1176%
-41.3388%
39.4452%
-238.4375%
314.3753%
211.3424%
4,021.0526%
-41.0604%
-86.9519%
-52.9013%
-105.3875%
-33.1%
101.7566%
-16.726%
-66.0527%
541.3061%
748.9926%
70.4613%
-33.9451%
-56.5654%
60.3619%
272.7933%
138.637%
-62.6099%
-145.6168%
-122.8824%
-182.9097%
-24.2683%
-26.1762%
-1.9798%
616.7997%
212.2799%
52.9577%
69.1192%
223.9026%
157.5639%
62.7458%
78.371%
-248.5223%
71.9112%
53.5858%
164.1003%
40.8781%
353.5152%
-30.3508%
714.8936%
22.1263%
-53.3072%
288.9193%
56.0062%
433.1622%
626.0309%
-182.764%
-9.9485%
87.8931%
-142.8256%
9,306.6667%
84.8157%
-123.4102%
105.6867%
105.887%
33.5612%
-226.6174%
34.5305%
-120.7087%
14.4929%
168.3654%
-153.6217%
169.4513%
5.2702%
85.9483%
78.8819%
89.4873%
50.6928%
-327.1389%
-125.2156%
-813.8258%
-5.6631%
18.0054%
-531.6218%
-56.7286%
-248.6253%
33.4671%
30.0788%
257.3356%
-130.5841%
-491.0434%
54.2514%
177.5577%
19.5514%
125.8699%
-510.3301%
-151.4819%
40.7444%
-494.1933%
88.3185%
57.4473%
54.6683%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.